Sign inJoin free

Watch / Three stocks for...

Three broker downgrades

7 Sept 20236:00

Three broker downgrades

General information only. ausbiz videos are general information only, produced by Ausbiz TV Pty Ltd, a media business that doesn’t give financial advice. They don’t take into account your objectives, financial situation or needs. Consider whether it’s right for you and read the PDS and TMD before acting on anything you watch.

About this video

Rudi Filapek-Vandyck from FNArena shares his insights into recent broker moves. His focus is on Cochlear (COH) and its strong share price performance. But Morgan Stanley (MS) seems to have taken a step back to a neutral hold, preparing investors for a less exuberant outlook.

Meanwhile, in the broader healthcare sphere, UBS has downgraded its rating from outperform to neutral for both Cochlear (COH) and Metcash (MTS) due to disappointing results.

In another news, avocados could be giving a boost to Costa Group (CGC), however, Macquarie seems to believe that a private equity firm won't lower its takeover offer, despite speculation otherwise.

Finally, let's not forget about ResMed (RMD) which Rudi says seems to have stirred value investors. Whether this trend will continue, only time will tell.

More like this

We value your privacy

We use essential cookies to make the site work. Non-essential cookies help us improve the experience. You can accept or reject non-essential cookies. Privacy policy